Kenneth Myszkowski
2021
Compensation breakdown
| Non-Equity Incentive Plan | $231,171 |
|---|---|
| Salary | $484,865 |
| Stock Awards | $4,603,800 |
| Other | $13,734 |
| Total | $5,333,570 |
Myszkowski received $4.6M in stock awards, accounting for 86% of the total pay in 2021.
Myszkowski also received $231.2K in non-equity incentive plan, $484.9K in salary and $13.7K in other compensation.
Rankings
In 2021, Kenneth Myszkowski's compensation ranked 2,423rd out of 12,397 executives tracked by ExecPay. In other words, Myszkowski earned more than 80.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,423 out of 12,397 | 81st |
Division Manufacturing | 958 out of 5,492 | 83rd |
Major group Chemicals And Allied Products | 363 out of 2,367 | 85th |
Industry group Drugs | 315 out of 2,090 | 85th |
Industry Pharmaceutical Preparations | 206 out of 1,537 | 87th |
Pay ratio
| Kenneth Myszkowski's Pay | $5,333,570 |
|---|---|
| Median Employee's Pay | $168,720 |
| Pay Ratio | 32to 1 |
In 2021, the annual total compensation of Kenneth Myszkowski was $5,333,570.
The annual total compensation of the median employee at Arrowhead Research was $168,720.
The ratio of Kenneth Myszkowski's pay to the pay of median employee was therefore 32 to one.
Myszkowski's colleagues
We found five more compensation records of executives who worked with Kenneth Myszkowski at Arrowhead Research in 2021.
2021
Christopher Anzalone
Arrowhead Research
Chief Executive Officer
2021
Patrick O'Brien
Arrowhead Research
General Counsel
2021
James Hamilton
Arrowhead Research
Sr. VP Discovery and
2021
James Hassard
Arrowhead Research
Chief Commercial Officer
2021
Javier San Martin
Arrowhead Research
Chief Medical Officer
News
January 26, 2022
January 27, 2021
January 28, 2020
January 25, 2019